<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60536">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02098135</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0182</org_study_id>
    <nct_id>NCT02098135</nct_id>
  </id_info>
  <brief_title>ArmeoSenso - Home Therapy and Assessment for Patients With Arm Impairments Based on Wearable Movement Sensors</brief_title>
  <official_title>Phase 1 Study of a Home Therapy and Assessment for Patients With Arm Impairments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      stroke, spinal cord injury, rehabilitation, home therapy, upper limb, arm, virtual reality,
      interia sensor,

        -  Trial with medical device
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Numbers of participant which can perform the ArmeoSenso - training.</measure>
    <time_frame>42 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in the Arm function</measure>
    <time_frame>42 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>WMFT (Wolf Motor Function Test), FMA-UL (Fugl-Meyer Assessment - Upper Limb), GRASSP (Graded and Redefined Assessment of Strength, Sensibility and Prehension)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Stroke</condition>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>ArmeoSenso</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The ArmeoSenso system is an easy to set up and use upper limb rehabilitation system for the home environment. It consists of a motion capture system based on wearable sensors in combination with a personal computer as well as a therapy software that provides an ergonomic user interface, therapy games and automated assessments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ArmeoSenso</intervention_name>
    <description>Virtual realty therapy with a touchscreen computer and movement sensors, over 42 days.</description>
    <arm_group_label>ArmeoSenso</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  18 years old

          -  Stroke or spinal cord injury in prehistory

          -  Motor deficits of the upper limb (s)

          -  Lifting the paretic arm against gravity possible AND

          -  Minimum amount of movement in the horizontal plane of 20 x 20 cm

          -  Ability and willingness to participate in the study

        Exclusion criteria:

          -  Severe aphasia

          -  Severe dementia

          -  Severe depression

          -  Relevant restriction of vision, which can not be compensated by aids (eg hemianopia)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Luft, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremia Held</last_name>
    <phone>+41 (0)44 255 11 11</phone>
    <email>jeremia.held@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Luft, Prof MD</last_name>
    <email>andreas.luft@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich, Divison of Neurology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>March 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
